Minimally Invasive Circulatory Assist Devices
Product Summary
Second Heart is developing a minimally invasive circulatory support platform based on proprietary aortic stent pump technology. The platform is deployed using low profile catheter-based techniques and will provide either acute or chronic circulatory support, depending on the specific needs of the patient. Second Heart’s Whisper is a catheter-based temporary assist pump to treat patients with acute decompensated heart failure and to provide circulatory support to those undergoing high-risk percutaneous coronary intervention (PCI) or Cardiogenic Shock. Our Freedom device is a wirelessly powered circulatory assist pumps that will provide chronic circulatory support for heart failure patients for full ambulatory outpatient / home therapy.
Key features of Second Heart’s platform include:
- The only device positioned to address all three of the major HF markets.
- Pump placement just above the renal arteries provides additional benefit for HF patients with kidney dysfunction.
- The only system to safely use the full inner diameter of the aorta to increase pump stability and reduce migration.
- A higher flow rate than other systems at over 7 liters per minute.
- Lowest RPMs and mechanical sheer dramatically reducing hemolysis.
- Lower risk of mechanical failure due to simple open frame design, mitigating blocked pumps typical in micro-axial designs.
OUR TEAM
Jeff Donofrio
Chief Executive Officer
Alex Richardson
Chief Technology Officer
Dr. Leslie Miller
Chief Medical Officer
Stuart Kozlick
Chief Operating Officer